174 related articles for article (PubMed ID: 25421458)
1. Performance of nonlinear mixed effects models in the presence of informative dropout.
Björnsson MA; Friberg LE; Simonsson US
AAPS J; 2015 Jan; 17(1):245-55. PubMed ID: 25421458
[TBL] [Abstract][Full Text] [Related]
2. A bias correction in testing treatment efficacy under informative dropout in clinical trials.
Kong F; Chen YF; Jin K
J Biopharm Stat; 2009 Nov; 19(6):980-1000. PubMed ID: 20183460
[TBL] [Abstract][Full Text] [Related]
3. Modelling placebo response in depression trials using a longitudinal model with informative dropout.
Gomeni R; Lavergne A; Merlo-Pich E
Eur J Pharm Sci; 2009 Jan; 36(1):4-10. PubMed ID: 19041717
[TBL] [Abstract][Full Text] [Related]
4. A joint model for nonlinear longitudinal data with informative dropout.
Hu C; Sale ME
J Pharmacokinet Pharmacodyn; 2003 Feb; 30(1):83-103. PubMed ID: 12800808
[TBL] [Abstract][Full Text] [Related]
5. Testing for the presence of multiple sources of informative dropout in longitudinal data.
Crawford SB; Hanfelt JJ
Stat Med; 2008 Sep; 27(21):4175-89. PubMed ID: 18613222
[TBL] [Abstract][Full Text] [Related]
6. Missing covariates in longitudinal data with informative dropouts: bias analysis and inference.
Roy J; Lin X
Biometrics; 2005 Sep; 61(3):837-46. PubMed ID: 16135036
[TBL] [Abstract][Full Text] [Related]
7. Multiple imputation compared with some informative dropout procedures in the estimation and comparison of rates of change in longitudinal clinical trials with dropouts.
Ali MW; Siddiqui O
J Biopharm Stat; 2000 May; 10(2):165-81. PubMed ID: 10803723
[TBL] [Abstract][Full Text] [Related]
8. The bayesian bias correction method of the first-order approximation of nonlinear mixed-effects models for population pharmacokinetics.
Funatogawa T; Funatogawa I
J Biopharm Stat; 2007; 17(3):381-92. PubMed ID: 17479388
[TBL] [Abstract][Full Text] [Related]
9. Accounting for dropout bias using mixed-effects models.
Mallinckrodt CH; Clark WS; David SR
J Biopharm Stat; 2001; 11(1-2):9-21. PubMed ID: 11459446
[TBL] [Abstract][Full Text] [Related]
10. Comparison of data analysis strategies for intent-to-treat analysis in pre-test-post-test designs with substantial dropout rates.
Salim A; Mackinnon A; Christensen H; Griffiths K
Psychiatry Res; 2008 Sep; 160(3):335-45. PubMed ID: 18718673
[TBL] [Abstract][Full Text] [Related]
11. A latent variable approach in simultaneous modeling of longitudinal and dropout data in schizophrenia trials.
Goyal N; Gomeni R
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1570-6. PubMed ID: 23602612
[TBL] [Abstract][Full Text] [Related]
12. Which individuals make dropout informative?
Geskus RB
Stat Methods Med Res; 2014 Feb; 23(1):91-106. PubMed ID: 22534427
[TBL] [Abstract][Full Text] [Related]
13. An assessment of the impact of informative dropout and nonresponse in measuring health-related quality of life using the EuroQol (EQ-5D) descriptive system.
Ratcliffe J; Young T; Longworth L; Buxton M
Value Health; 2005; 8(1):53-8. PubMed ID: 15841894
[TBL] [Abstract][Full Text] [Related]
14. Bias reduction with an adjustment for participants' intent to dropout of a randomized controlled clinical trial.
Leon AC; Demirtas H; Hedeker D
Clin Trials; 2007; 4(5):540-7. PubMed ID: 17942469
[TBL] [Abstract][Full Text] [Related]
15. Issues in use of SAS PROC.MIXED to test the significance of treatment effects in controlled clinical trials.
Ahn C; Tonidandel S; Overall JE
J Biopharm Stat; 2000 May; 10(2):265-86. PubMed ID: 10803729
[TBL] [Abstract][Full Text] [Related]
16. HIV viral dynamic models with dropouts and missing covariates.
Wu L
Stat Med; 2007 Jul; 26(17):3342-57. PubMed ID: 17221835
[TBL] [Abstract][Full Text] [Related]
17. Modeling event count data in the presence of informative dropout with application to bleeding and transfusion events in myelodysplastic syndrome.
Diao G; Zeng D; Hu K; Ibrahim JG
Stat Med; 2017 Sep; 36(22):3475-3494. PubMed ID: 28560768
[TBL] [Abstract][Full Text] [Related]
18. The analysis of incomplete cost data due to dropout.
Oostenbrink JB; Al MJ
Health Econ; 2005 Aug; 14(8):763-76. PubMed ID: 15729743
[TBL] [Abstract][Full Text] [Related]
19. Joint modelling with competing risks of dropout for longitudinal analysis of health-related quality of life in cancer clinical trials.
Cuer B; Conroy T; Juzyna B; Gourgou S; Mollevi C; Touraine C
Qual Life Res; 2022 May; 31(5):1359-1370. PubMed ID: 34817733
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the nonparametric estimation method in NONMEM VI.
Savic RM; Kjellsson MC; Karlsson MO
Eur J Pharm Sci; 2009 Apr; 37(1):27-35. PubMed ID: 19159684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
